Nephros Valuation
| NEPH Stock | USD 2.19 0.05 2.34% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Nephros secures a last-minute Real Value of $2.55 per share. The latest price of the firm is $2.19. Our model forecasts the value of Nephros from analyzing the firm fundamentals such as Return On Equity of -0.18, current valuation of 20.09 M, and Profit Margin of (0.11) % as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend purchasing undervalued stocks and trading away overvalued stocks since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting Nephros' valuation include:
Price Book 2.523 | Enterprise Value 20.1 M | Enterprise Value Ebitda (13.70) | Price Sales 1.4811 | Enterprise Value Revenue 1.3075 |
Undervalued
Today
Please note that Nephros' price fluctuation is risky at this time. Calculation of the real value of Nephros is based on 3 months time horizon. Increasing Nephros' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Nephros is useful when determining the fair value of the Nephros stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Nephros. Since Nephros is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nephros Stock. However, Nephros' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.19 | Real 2.55 | Target 3.0 | Hype 2.02 | Naive 2.01 |
The real value of Nephros Stock, also known as its intrinsic value, is the underlying worth of Nephros Company, which is reflected in its stock price. It is based on Nephros' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Nephros' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nephros' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nephros helps investors to forecast how Nephros stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nephros more accurately as focusing exclusively on Nephros' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Nephros' intrinsic value based on its ongoing forecasts of Nephros' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Nephros' closest peers. When choosing an evaluation method for Nephros, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Nephros Investments |
|
Nephros Valuation Trend
Knowing Nephros' actual value is paramount for traders to make sound investment determinations. Nephros' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Nephros' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Nephros' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Nephros Market Cap
Nephros is considered to be number one stock in market capitalization category among related companies. Market capitalization of Consumer Discretionary industry is now estimated at about 204.12 Billion. Nephros adds roughly 22.56 Million in market capitalization claiming only tiny portion of stocks in Consumer Discretionary industry.Nephros Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Nephros's current stock value. Our valuation model uses many indicators to compare Nephros value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nephros competition to find correlations between indicators driving Nephros's intrinsic value. More Info.Nephros is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in price to book category among related companies . The current Price To Book Ratio is estimated to decrease to 3.48. Comparative valuation analysis is a catch-all model that can be used if you cannot value Nephros by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nephros' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nephros' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nephros' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nephros and how it compares across the competition.
About Nephros Valuation
The stock valuation mechanism determines the current worth of Nephros on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Nephros. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nephros based exclusively on its fundamental and basic technical indicators. By analyzing Nephros's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Nephros's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nephros. We calculate exposure to Nephros's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nephros's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 8.2 M | 8.6 M | |
| Pretax Profit Margin | (0.11) | (0.12) | |
| Operating Profit Margin | (0.11) | (0.12) | |
| Net Loss | (0.11) | (0.12) | |
| Gross Profit Margin | 0.58 | 0.34 |
8 Steps to conduct Nephros' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nephros' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nephros' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Nephros' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Nephros' revenue streams: Identify Nephros' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Nephros' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Nephros' growth potential: Evaluate Nephros' management, business model, and growth potential.
- Determine Nephros' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nephros' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Nephros Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Nephros does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 10.4 M |
Nephros Current Valuation Indicators
Valuation refers to the process of determining the present value of Nephros and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Nephros we look at many different elements of the entity such as Nephros's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Nephros' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Nephros' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Nephros, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Nephros' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Nephros' worth.When determining whether Nephros offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Nephros Stock analysis
When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 1.371 | Quarterly Revenue Growth 0.272 | Return On Assets (0.09) | Return On Equity (0.18) |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.